Review Article

Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis

Figure 5

Risk of adverse primary outcomes in specific subgroups.
794078.fig.005